HTB news: Stopping ART in an ATI, AIDS 2026 online, LEN PrEP blocked in UK

1 October 2026. Related: News.

October news – September news – August news – All back issues

Recent HTB highlights

• Stopping ART as part of HIV cure-related research: experiences from the RIO study

Experiences of participants who stop ART as part of a research study – including surprises that are under-appreciated when planning ATI studies.

• NICE fails to approve lenacapavir for HIV PrEP: will feedback lead to the right outcome in November?

This disappointing decision was not unexpected but could perhaps be overturned with additional stakeholder feedback. There is little benefit in i-Base reporting benefits of new research unless this leads to access.

• Macaque study eradicates simian HIV (SHIV) with combination treatment in very early infection

Intriguing animal study showing a combination of bNAbs and ART prevented establishing SHIV in infant macaques,

• AIDS 2026: PrEP efficacy depends on adherence not biology – PrEP access depends on politics

Review of plenary lecture by leading researcher Raphael Landovitz on the PrEP efficacy, recent UK guidelines and the importance of politics to enable global access.

• AIDS 2026: Free open access for all

All proceedings and resources from this essential conference are now online open-access.

All reports

• All back issues

Subscribe to HTB by email to receive the latest news every 3-4 weeks.

Reports will also be posted to social media.

Twitter (X) – Bluesky – Facebook – Instagram